CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma
Authors
Keywords
-
Journal
BLOOD
Volume 128, Issue 7, Pages 959-970
Publisher
American Society of Hematology
Online
2016-06-16
DOI
10.1182/blood-2016-03-703439

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.